Ohnewein, B.; Shomanova, Z.; Paar, V.; Topf, A.; Jirak, P.; Fiedler, L.; Granitz, C.; Van Almsick, V.; Semo, D.; Zagidullin, N.;
et al. Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine. J. Clin. Med. 2023, 12, 3083.
https://doi.org/10.3390/jcm12093083
AMA Style
Ohnewein B, Shomanova Z, Paar V, Topf A, Jirak P, Fiedler L, Granitz C, Van Almsick V, Semo D, Zagidullin N,
et al. Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine. Journal of Clinical Medicine. 2023; 12(9):3083.
https://doi.org/10.3390/jcm12093083
Chicago/Turabian Style
Ohnewein, Bernhard, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Zagidullin,
and et al. 2023. "Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine" Journal of Clinical Medicine 12, no. 9: 3083.
https://doi.org/10.3390/jcm12093083
APA Style
Ohnewein, B., Shomanova, Z., Paar, V., Topf, A., Jirak, P., Fiedler, L., Granitz, C., Van Almsick, V., Semo, D., Zagidullin, N., Dieplinger, A.-M., Sindermann, J., Reinecke, H., Hoppe, U. C., Pistulli, R., & Motloch, L. J.
(2023). Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine. Journal of Clinical Medicine, 12(9), 3083.
https://doi.org/10.3390/jcm12093083
